One possible explanation for this discrepancy is that we recruited patients with NSCLC in our cohort, while NSE is primarily a marker for the diagnosis and monitoring of treatment in patients with small cell lung cancer (SCLC).29, 30 In this study, the changes of SP70 levels are obviously greater than above tumor biomarkers. The gene discussed is ENO2; the disease is non-small cell lung carcinoma.